Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06581887 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies

Name: Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies — clinical trial record (NCT06581887)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: D-BRAIN

StatusUnknown

PhaseNot specified

SponsorUniversity College, London

Started2022-09-13

View on ClinicalTrials.gov ↗

Record status

This record was last updated September 3, 2024 (before its estimated November 19, 2024 completion). Its status may not reflect the trial's current state.

Study aims to develop and to evaluate the neurophysiological and physiological response to a classical conditioning task.To better understand how Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) impacts mental health and how to assess it. Participants invited to complete questionnaires about behaviour, cognitive function and social interactions, complete computer tasks and have an optional MRI brain scan,

Amendment history 1 change detected by DataLookout

2026-09-06

Trial status changed: Recruiting → Unknown

Trial Details

NCT Number	NCT06581887
Lead Sponsor	University College, London Collaborators: Sarepta Therapeutics, Inc.
Conditions	DMD, BMD
Enrollment	100 participants
Start Date	2022-09-13
Primary Completion	2024-11-19 (estimated)
Study Completion	2024-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-09-03